After suffering two massive strokes, a Lenawee County man is suing the manufacturer of the COVID drug, Remdesivir, Gilead Sciences Inc., and a Washtenaw County hospital.

Ven Johnson Law is suing Remdesivir’s manufacturer over claims that the drug contained glass particles when it was administered to Dan Nowacki in November 2021 by staff at St. Joseph Mercy Hospital in Chelsea.

Because of a tainted COVID drug, Nowacki’s wife Kathleen and their son Luke are now providing round-the-clock care.

During a news conference, Ven Johnson said “One of the things that we’re going to define in this lawsuit, and we’re going to figure out is exactly what did they know when.”

According to the lawsuit, at least two of the five doses Nowacki received during his stay were from the faulty batch.

He had a stroke a few days later.

Gilead Sciences, Inc., issued a voluntary recall the following month.

Johnson said that “Once Gilead came forward in the first week of December, why weren’t the patients located? And it was discovered, so maybe Dan could have been spared his second stroke in December.”

“But Nowacki and his family weren’t made aware of it until several months later, in April 2022, when the hospital sent a letter confirming he was given at least two doses that were part of the nationwide recall.

‘Their argument, ladies and gentlemen, has been, ‘Yeah, we know we voluntarily recalled. Yeah, we know there’s glass particulate in it, and we know that two doses were given to Dan, and we know we had a stroke. But since we followed the FDA guidelines and were approved, we have drug immunity. You can’t sue us because it was approved by the FDA.'”

But a Michigan judge ruled for the first time that the “Public Readiness and Emergency Preparedness” (PREP) Act does not shield a drugmaker from liability when its medication is contaminated with glass particles. 

‘FDA never approved this drug in the form that it was given to Mr. Nowacki, period,’ Ken Khara, attorney at Ven Johnson Law, said.

A spokesperson for the hospital said they are aware of the ruling and cannot comment during ongoing litigation.”

However, this article still has to be read in between the lines, because, the bottom line message is that Remdesivir is beneficial but this man was unfortunate to be administered two out of five doses which happened to be of a bad batch.

We have seen how medical publications have pointed at Remdesivir for Acute Kidney Failure and Bradycardia.

What about all the Remdesivir which was given to the alleged Covid-19 patients while being under anaesthetic and on the ventilator during the alleged Covid-19 pandemic?

Leave a Reply